Corvia Medical closes $55 million funding round to complete confirmatory trial and pursue FDA approval of Corvia Atrial Shunt
Existing investors provide funding to finish international RESPONDER-HF trial
TEWKSBURY, Mass., June 17, 2025 /CNW/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today announced the successful closure of a $55 million funding round from the company's existing investment syndicate of Third Rock Ventures, General Catalyst Partners, AccelMed, Lumira Ventures, and two strategic investors.
The funds will be used to complete the ongoing RESPONDER-HF trial, a double-blinded, randomized, sham-controlled, confirmatory trial of the Corvia ® Atrial Shunt currently underway at more than 65 institutions on three continents. The study is expected to generate the final supportive clinical data required for FDA approval of the shunt as a breakthrough treatment for heart failure with preserved and mildly reduced ejection fraction (HFpEF/HFmrEF).
"We are profoundly grateful for the unwavering support of our longstanding investors as we advance toward FDA submission of the Corvia Atrial Shunt," said George Fazio, CEO of Corvia Medical. "Their commitment furthers our mission to bring this transformative heart failure treatment to millions of patients worldwide."
Paul LaViolette, Board Chair of Corvia Medical, added, "We firmly believe Corvia has the potential to fundamentally alter the landscape of heart failure treatment, and our investors share that vision. With these resources, we are well-equipped to drive the company through the approval process and introduce this groundbreaking therapy to the market."
About heart failure (HF) and the Corvia Atrial Shunt
More than 26 million people worldwide have HF, and the majority have HFpEF, making it the largest unmet clinical need in cardiovascular medicine. The Corvia Atrial Shunt is designed to reduce elevated left atrial pressure (LAP), the primary contributor to HF symptoms, by creating a passage between the left and right atria, reducing HF events and improving quality of life. The Corvia Atrial Shunt was granted Breakthrough Device designation by the FDA in 2019. For information regarding RESPONDER-HF study eligibility, please visit https://treatmyheartfailure.com.
Corvia Medical, Inc. is revolutionizing the treatment of heart failure through novel transcatheter cardiovascular devices. Founded in 2009 and headquartered in Tewksbury, MA, privately-held Corvia is dedicated to transforming the standard of care for heart failure treatment, enabling patients to reclaim their lives. Visit https://corviamedical.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
2 hours ago
- Globe and Mail
Kraft Heinz pulling certain artificial dyes from its US products in 2027
Kraft Heinz will be pulling certain artificial dyes from its U.S. products starting in 2027 and will no longer roll out new products with the dyes. The move comes nearly two months after U.S. health officials said that they would urge foodmakers to phase out petroleum-based artificial colors in the nation's food supply. Kraft Heinz said Tuesday that almost 90% of its U.S. products already don't contain food, drug & cosmetic colors, but that the products that do still use the dyes will have them removed by the end of 2027. FD&C colors are synthetic additives that are approved by the U.S. Food and Drug Administration for use in food, drugs and cosmetics. The company said that it will instead use natural colors for the products. 'The vast majority of our products use natural or no colors, and we've been on a journey to reduce our use of FD&C colors across the remainder of our portfolio," Pedro Navio, North America President at Kraft Heinz, said in a statement. Kraft Heinz stripped artificial colors, flavors and preservatives from its macaroni and cheese in 2016 and said it has never used artificial dyes in its ketchup. The company plans to work with licensees of its brands to encourage them to remove the dyes. In April Food and Drug Administration Commissioner Marty Makary said at a news conference that the agency would take steps to eliminate the synthetic dyes by the end of 2026, largely by relying on voluntary efforts from the food industry. Health advocates have long called for the removal of artificial dyes from foods, citing mixed studies indicating they can cause neurobehavioral problems, including hyperactivity and attention issues, in some children. The FDA has maintained that the approved dyes are safe and that 'the totality of scientific evidence shows that most children have no adverse effects when consuming foods containing color additives.' The FDA currently allows 36 food color additives, including eight synthetic dyes. In January, the agency announced that the dye known as Red 3 — used in candies, cakes and some medications — would be banned in food by 2027 because it caused cancer in laboratory rats. Artificial dyes are used widely in U.S. foods. In Canada and in Europe — where synthetic colors are required to carry warning labels — manufacturers mostly use natural substitutes. Several states, including California and West Virginia, have passed laws restricting the use of artificial colors in foods. Many U.S. food companies are already reformulating their foods, according to Sensient Colors, one of the world's largest producers of food dyes and flavorings. In place of synthetic dyes, foodmakers can use natural hues made from beets, algae and crushed insects and pigments from purple sweet potatoes, radishes and red cabbage.
Winnipeg Free Press
2 hours ago
- Winnipeg Free Press
Kraft Heinz pulling certain artificial dyes from its US products in 2027
Kraft Heinz will be pulling certain artificial dyes from its U.S. products starting in 2027 and will no longer roll out new products with the dyes. The move comes nearly two months after U.S. health officials said that they would urge foodmakers to phase out petroleum-based artificial colors in the nation's food supply. Kraft Heinz said Tuesday that almost 90% of its U.S. products already don't contain food, drug & cosmetic colors, but that the products that do still use the dyes will have them removed by the end of 2027. FD&C colors are synthetic additives that are approved by the U.S. Food and Drug Administration for use in food, drugs and cosmetics. The company said that it will instead use natural colors for the products. 'The vast majority of our products use natural or no colors, and we've been on a journey to reduce our use of FD&C colors across the remainder of our portfolio,' Pedro Navio, North America President at Kraft Heinz, said in a statement. Kraft Heinz stripped artificial colors, flavors and preservatives from its macaroni and cheese in 2016 and said it has never used artificial dyes in its ketchup. The company plans to work with licensees of its brands to encourage them to remove the dyes. Wednesdays Columnist Jen Zoratti looks at what's next in arts, life and pop culture. In April Food and Drug Administration Commissioner Marty Makary said at a news conference that the agency would take steps to eliminate the synthetic dyes by the end of 2026, largely by relying on voluntary efforts from the food industry. Health advocates have long called for the removal of artificial dyes from foods, citing mixed studies indicating they can cause neurobehavioral problems, including hyperactivity and attention issues, in some children. The FDA has maintained that the approved dyes are safe and that 'the totality of scientific evidence shows that most children have no adverse effects when consuming foods containing color additives.' The FDA currently allows 36 food color additives, including eight synthetic dyes. In January, the agency announced that the dye known as Red 3 — used in candies, cakes and some medications — would be banned in food by 2027 because it caused cancer in laboratory rats. Artificial dyes are used widely in U.S. foods. In Canada and in Europe — where synthetic colors are required to carry warning labels — manufacturers mostly use natural substitutes. Several states, including California and West Virginia, have passed laws restricting the use of artificial colors in foods. Many U.S. food companies are already reformulating their foods, according to Sensient Colors, one of the world's largest producers of food dyes and flavorings. In place of synthetic dyes, foodmakers can use natural hues made from beets, algae and crushed insects and pigments from purple sweet potatoes, radishes and red cabbage.
Cision Canada
3 hours ago
- Cision Canada
BetaPro by Global X Expands Canada's Largest Leveraged ETF Suite with New 3x and -3x U.S. Index ETFs & Announces Fee Rebates Français
With announced rebate, new ETFs from Canada's leader in leveraged funds are the lowest-cost 3x and –3x ETFs currently available in the world TORONTO, June 17, 2025 /CNW/ - Global X Investments Canada Inc. (" Global X" or the " Manager") is announcing the launch of four new ETFs (the " New ETFs") within its BetaPro by Global X (" BetaPro") suite that provide three-times (" 3x") and minus three-times (" -3x") exposure to the Nasdaq-100 ® and S&P 500 ® indices – the highest amount of leverage available in Canada through exchange traded funds (" ETFs") without exemptive relief. Units of the ETFs begin trading today on the Toronto Stock Exchange (" TSX"). BetaPro is the first, largest and longest-running family of leveraged, inverse, and inverse-leveraged ETFs in Canada. With more than 17 years of trading in Canada across 32 ETFs, BetaPro by Global X is the Canadian leader in this ETF category. In addition to the launch, the Manager is simultaneously announcing a 50-basis points rebate (the " Rebates") on the New ETFs until December 31, 2025. For the duration of the Rebates, the effective management fee for the New ETFs is 0.65%, making them the lowest-cost 3x and –3x ETFs currently available, globally. " From launching the world's first leveraged commodities ETFs in 2008 to its position today as Canada's leading leveraged, inverse and inverse leveraged ETF family, BetaPro has been the source for sophisticated traders in Canada seeking effective ETFs solutions for amplifying exposure," said Chris McHaney, Executive Vice President, Investment Management & Strategy at Global X. " In addition to adding 3x and –3x to Canada's largest suite of leveraged, inverse and inverse leveraged ETFs, we're offering a sizeable fee rebate, making these new ETFs the lowest cost of their kind, anywhere in the world, during the rebate." The New ETFs offer amplified exposure for sophisticated investors to two of the largest and most actively traded U.S. benchmarks – the S&P 500 ® and the Nasdaq-100 ® (the " Underlying Index"). Currency movements can introduce unwanted noise and reduce the precision of tactical trades. The New ETFs employ currency hedging to seek to neutralize U.S. dollar exposure, providing performance that more accurately reflects the underlying U.S. equity indices. More details on the New ETFs are outlined in the table below: *Plus applicable sales tax The New ETFs are designed to provide daily investment results, before fees, expenses, distributions, brokerage commissions and other transaction costs, that endeavour to correspond to 300% of the daily performance of the specified Underlying Index, or 300% of the inverse of the daily performance of the specified Underlying Index. The ETFs do not seek to achieve their stated investment objective over a period of time greater than one day and are not for investors who do not intend to actively monitor their investments daily. Any U.S. dollar gains or losses as a result of the ETFs' investments will be hedged back to the Canadian dollar to the best of their ability. The Canadian Advantage: Investing in Canadian-listed vs. U.S.-listed 3x and –3x ETFs: Historically, Canadians seeking to access 3x and –3x ETFs have had to turn to the U.S. market for access. According to Investor Economics, Canadians currently hold an estimated $4 billion CAD in U.S.-listed leveraged, inverse and inverse leveraged funds. Now, with their expansion into Canada, Canadians have the choice to invest in 3x and –3x ETFs listed on the TSX, which could potentially result in improved tax and currency outcomes, relative to investing in U.S.-listed alternatives. By trading funds on foreign exchanges, including those in the U.S., Canadian investors holding those assets are exposed to foreign currency exposure risk and potential tax implications, such as U.S. estate tax, as well as additional tax filings. Unless a Canadian investor has a U.S. dollar trading account, they will have to convert from Canadian dollars into U.S. dollars each time they enter and exit the ETF. Considering these investments are meant for daily, short-term, tactical trades, those costs can significantly undercut the efficiency of U.S.-listed 3x and -3x ETFs, which are also designed for daily usage. " Since the start of 2025, Canadians have been looking for alternatives to U.S. products, so it only makes sense to offer them a way to repatriate some of their investment dollars," said Chris McHaney. "As Canada's leader in leveraged, inverse, and inverse leveraged ETFs, we wanted to give sophisticated Canadian traders a better way to harness market volatility and magnify their exposure, here at home." Data from the Chicago Board Options Exchange's Volatility Index shows volatility has recently picked up, with the highest spike recorded in April of this year, highlighting the potential for continued opportunity for sophisticated active traders. Inverse strategies, including –3x ETFs, can also be used to potentially profit off a short-term pullback. The launch of the 3x leveraged and 3x inverse leverage ETFs expands BetaPro's already extensive lineup of leveraged, inverse, and inverse-leveraged ETFs for sophisticated investors to 32, spanning four market indices, five major Canadian sectors, four major commodities, as well as an inverse bitcoin-focused ETF. Until recently, the highest available Canadian-listed ETFs that provided a fixed percentage of leverage on a particular index, sector of commodity were only available were up a maximum of 2x and -2x. The Rebates are effective upon the launch of the New ETFs. The New ETFs are still subject to operating expenses, which are included in the Management Expense Ratio (" MER") and are still subject to trading costs which are included in the Trading Expense Ratio (" TER"). The New ETFs closed their initial offering of units to their designated broker and will begin trading today on the TSX. About Global X Investments Canada Inc. ( Global X Investments Canada Inc. ("Global X") is an innovative financial services company and offers one of the largest suites of exchange traded funds in Canada. The Global X product family includes a broadly diversified range of solutions for investors of all experience levels to meet their investment objectives in a variety of market conditions. Global X has approximately $40 billion of assets under management and 146 ETFs listed on major Canadian stock exchanges. Global X is a wholly owned subsidiary of the Mirae Asset Financial Group, which manages more than $900 billion of assets across 19 countries and global markets around the world. Commissions, management fees, and expenses all may be associated with an investment in products (the "Global X Funds") managed by Global X Investments Canada Inc. The Global X Funds are not guaranteed, their values change frequently and past performance may not be repeated. Certain Global X Funds may have exposure to leveraged investment techniques that magnify gains and losses which may result in greater volatility in value and could be subject to aggressive investment risk and price volatility risk. Such risks are described in the prospectus. The Global X Money Market Funds are not covered by the Canada Deposit Insurance Corporation, the Federal Deposit Insurance Corporation, or any other government deposit insurer. There can be no assurances that the money market fund will be able to maintain its net asset value per security at a constant amount or that the full amount of your investment in the Funds will be returned to you. Past performance may not be repeated. The prospectus contains important detailed information about the Global X Funds. Please read the relevant prospectus before investing. The Global X Funds include our BetaPro products (the "BetaPro Products"). The BetaPro Products are alternative mutual funds within the meaning of National Instrument 81-102 Investment Funds and are permitted to use strategies generally prohibited by conventional mutual funds: the ability to invest more than 10% of their net asset value in securities of a single issuer, to employ leverage, and engage in short selling to a greater extent than is permitted in conventional mutual funds. While these strategies will only be used in accordance with the investment objectives and strategies of the BetaPro Products, during certain market conditions they may accelerate the risk that an investment in shares of a BetaPro Product decreases in value. The BetaPro Products include the 3x and -3x ETFs described in this press release. The 3x and -3x ETFs will use leveraged investment techniques that can magnify gains and losses and may result in greater volatility of returns. These 3x and -3x ETFs are subject to leverage risk and may be subject to aggressive investment risk and price volatility risk, among other risks, which are described in their prospectus. Each 3x and -3x ETF seeks a return, before fees and expenses, that is equal to either 300% or –300% of the performance of a specified underlying index (the "Target") for a single day. Due to the compounding of daily returns, a 3x and -3x ETF's returns over periods other than one day will likely differ in amount and possibly direction from the performance of their respective Target(s) for the same period. Hedging costs charged to BetaPro Products reduce the value of the forward price payable to that ETF. An investment in any of the BetaPro Products is not intended as a complete investment program and is appropriate only for sophisticated investors who have the capacity to absorb a loss of some or all of their investment. Please read the full risk disclosure in the prospectus before investing. Investors should monitor their holdings in BetaPro Products and their performance at least as frequently as daily to ensure such investment(s) remain consistent with their investment strategies. Certain statements may constitute a forward-looking statement, including those identified by the expression "expect" and similar expressions (including grammatical variations thereof). The forward-looking statements are not historical facts but reflect the author's current expectations regarding future results or events. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. These and other factors should be considered carefully and readers should not place undue reliance on such forward-looking statements. These forward-looking statements are made as of the date hereof and the authors do not undertake to update any forward-looking statement that is contained herein, whether as a result of new information, future events or otherwise, unless required by applicable law. Standard & Poor's ®" and "S&P ®" are registered trademarks of Standard & Poor's Financial Services LLC ("S&P") and have been licensed for use by Global X Investments Canada Inc. ("Global X") The Global X ETFs are not sponsored, endorsed, sold or promoted by S&P, and S&P makes no representation, warranty or condition regarding the advisability of buying, selling or holding units/shares in the Global X ETFs. Nasdaq ®, Nasdaq-100 ®, and Nasdaq-100 Index ® are trademarks of The Nasdaq Stock Market, Inc. (which with its affiliates is referred to as the "Corporations") and are licensed for use by Global X Investments Canada Inc. The Product(s) have not been passed on by the Corporations as to their legality or suitability. The Product(s) are not issued, endorsed, sold, or promoted by the Corporations. THE CORPORATIONS MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO THE PRODUCT(S). This communication is intended for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to purchase investment products (the "Global X Funds") managed by Global X Investments Canada Inc. and is not, and should not be construed as, investment, tax, legal or accounting advice, and should not be relied upon in that regard. Individuals should seek the advice of professionals, as appropriate, regarding any particular investment. Investors should consult their professional advisors prior to implementing any changes to their investment strategies. These investments may not be suitable to the circumstances of an investor. Global X Investments Canada Inc. ("Global X") is a wholly owned subsidiary of Mirae Asset Global Investments Co., Ltd. ("Mirae Asset"), the Korea-based asset management entity of Mirae Asset Financial Group. Global X is a corporation existing under the laws of Canada and is the manager and investment manager of the Global X Funds. © 2025 Global X Investments Canada Inc. All Rights Reserved. SOURCE Global X Investments Canada Inc.
